The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

MDS Clinical Research Consortium

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e224-e227
JournalHaematologica
Volume101
Issue number6
DOIs
StatePublished - May 31 2016

Keywords

  • Hypomethylating agent
  • MDS
  • Prognostic models

ASJC Scopus subject areas

  • Hematology

Cite this